Telmisartan
DrugBank ID: DB00966
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 5 |
| DL Only | 45 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| obsolete susceptibility to ischemic stroke | 0.9999 | KG+DL |
| Prinzmetal angina | 0.9998 | DL |
| brain stem infarction | 0.9998 | DL |
| stroke disorder | 0.9998 | KG+DL |
| ABri amyloidosis | 0.9997 | DL |
| cerebral infarction | 0.9996 | KG+DL |
| cerebral artery occlusion | 0.9995 | DL |
| cerebrovascular disorder | 0.9995 | KG+DL |
| pulmonary hypertension owing to lung disease and/or hypoxia | 0.9993 | DL |
| pulmonary hypertension with unclear multifactorial mechanism | 0.9993 | DL |
| malignant hypertensive renal disease | 0.9993 | DL |
| malignant renovascular hypertension | 0.9993 | DL |
| intracerebral hemorrhage | 0.9993 | DL |
| Braddock syndrome | 0.9992 | DL |
| hypertensive disorder | 0.9990 | KG+DL |
| cerebral arterial disease | 0.9990 | DL |
| MRI defined brain infarct | 0.9989 | DL |
| autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 0.9979 | DL |
| brain small vessel disease 1 with or without ocular anomalies | 0.9977 | DL |
| chronic pulmonary heart disease | 0.9965 | DL |
| diabetic nephropathy | 0.9939 | DL |
| spinal cord ischemia | 0.9938 | DL |
| myocardial infarction | 0.9935 | DL |
| posteroinferior myocardial infarction | 0.9929 | DL |
| posterolateral myocardial infarction | 0.9929 | DL |
| septal myocardial infarction | 0.9917 | DL |
| cholesterol embolism | 0.9906 | DL |
| sagittal sinus thrombosis | 0.9885 | DL |
| homozygous familial hypercholesterolemia | 0.9860 | DL |
| hypoalphalipoproteinemia | 0.9859 | DL |
| chronic renal failure syndrome | 0.9839 | DL |
| cardiac tamponade | 0.9838 | DL |
| coronary thrombosis | 0.9803 | DL |
| congenital coronary artery anomaly | 0.9691 | DL |
| transient ischemic attack (disease) | 0.9604 | DL |
| thrombophilia, familial, due to decreased release of tissue plasminogen activator | 0.9586 | DL |
| angiokeratoma | 0.9492 | DL |
| coronary stenosis | 0.9477 | DL |
| atrial fibrillation (disease) | 0.9444 | DL |
| obsolete familial combined hyperlipidemia | 0.9391 | DL |
| sick sinus syndrome 2, autosomal dominant | 0.9366 | DL |
| ABeta amyloidosis | 0.9356 | DL |
| chronic kidney disease | 0.9308 | DL |
| acute coronary syndrome | 0.9304 | DL |
| sarcoglycanopathy | 0.9144 | DL |
| end stage renal failure | 0.9115 | DL |
| hemoglobinopathy | 0.8926 | DL |
| cavernous sinus thrombosis | 0.8908 | DL |
| lateral sinus thrombosis | 0.8908 | DL |
| Wildervanck syndrome | 0.8817 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.